Physician profile
Jong Chen
NPI 1346313228
$1,054.20
in general payments reported to CMS, 2019-2025
13 companies · $19.79 in 2025
The $19.79 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $11.48 · 2021: $173 · 2022: $174 · 2023: $313 · 2024: $33.41 · 2025: $19.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.35 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $719.10 | 2019-2024 | Erleada, Akeega |
| Abbvie INC. | $105.37 | 2021-2025 | Lupron Depot |
| Astellas Pharma US INC | $63.11 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.82 | 2019 | |
| Myovant Sciences INC. | $24.20 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $22.07 | 2022 | |
| Pfizer INC. | $20.03 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $15.74 | 2019 | |
| Dendreon Pharmaceuticals LLC | $15.28 | 2019 | |
| Boston Scientific Corporation | $14.01 | 2019 | |
| Ge Healthcare | $13.13 | 2023 | |
| Healthtronics Stone Solutions, LLC | $8.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jong Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.